SCHEMBL17816163

SCHEMBL17816163

CC1(C)CCCC(Sc2cc(C(=O)Nc3ccc(F)c(Cl)c3)ccc2I)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MAOB P27338 4/20 0.41
MAOA P21397 2/20 0.41
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CHRM1 P11229 1/20 0.40
CCR2 P41597 1/20 0.40
KCNQ3 O43525 1/20 0.39
KCNQ2 O43526 1/20 0.39
KCNE1 P15382 1/20 0.39
KCNQ1 P51787 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
TAS1R2 Q8TE23 1/20 0.38
CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17784158 0.93 NPC1 (0.47) NPC1RAB9AMAOBMAOAMAPT
SCHEMBL17816165 0.89 NPC1 (0.47) NPC1RAB9AMAOBMAOAMAPT
SCHEMBL17816138 0.87 NPC1 (0.50) NPC1RAB9AMAOBMAOAMAPT
SCHEMBL17816177 0.85 NPC1 (0.47) NPC1RAB9AMAOBMAOAMAPT
SCHEMBL17816169 0.84 NPC1 (0.47) NPC1RAB9AMAOBMAOAMAPT
SCHEMBL17816113 0.83 NPC1 (0.47) NPC1RAB9AMAOBMAOAMAPT
SCHEMBL17816104 0.83 NPC1 (0.47) NPC1RAB9AMAOBMAOAMAPT
SCHEMBL17816127 0.83 NPC1 (0.47) NPC1RAB9AMAOBMAOAMAPT
SCHEMBL17816170 0.83 NPC1 (0.46) NPC1RAB9AMAOBMAOANPSR1
SCHEMBL17816180 0.83 NPC1 (0.46) NPC1RAB9AMAOBMAOANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089990-A1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS, INC. (US) 2016-06-09 WO disclosed